$PHCI
Panamera Holdings Corp

2020 Q2 Form 10-Q Financial Statement

#000164033420001512 Filed on June 15, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.00K $0.00 $10.00K
YoY Change -100.0% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.238K $4.539K $5.728K
YoY Change 15.4% -54.61% -42.72%
Operating Profit -$5.238K -$4.539K -$5.728K
YoY Change 15.4%
Interest Expense $1.217K $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.217K -$911.00 -$840.00
YoY Change 33.59%
Pretax Income -$6.455K -$5.450K -$6.568K
YoY Change 18.44% -45.5% -34.32%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.455K -$5.450K -$6.568K
YoY Change 18.44% -45.5% -34.32%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 17.99M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $3.174K $1.602K $1.242K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.174K $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$3.174K $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.174K $0.00 $0.00
Total Long-Term Assets -$3.174K $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.00K $0.00 $10.00K
YoY Change -100.0% 0.0%
Accrued Expenses $10.00K $10.00K $0.00
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $100.0K $80.00K $70.00K
YoY Change 25.0% 100.0% 75.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $120.0K $90.00K $80.00K
YoY Change 33.33% 80.0% 60.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $120.0K $90.00K $80.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $120.0K $90.00K $80.00K
YoY Change 33.33% 80.0% 60.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$114.9K -$83.73K -$78.28K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$6.455K -$5.450K -$6.568K
YoY Change 18.44% -45.5% -34.32%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$10.00K -$10.00K $0.00
YoY Change 0.0% 0.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 20.00K 0.000
YoY Change -100.0% 100.0%
NET CHANGE
Cash From Operating Activities -10.00K -10.00K 0.000
Cash From Investing Activities
Cash From Financing Activities 0.000 20.00K 0.000
Net Change In Cash -10.00K 10.00K 0.000
YoY Change -200.0%
FREE CASH FLOW
Cash From Operating Activities -$10.00K -$10.00K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17990000 shares
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
671 USD
us-gaap Net Income Loss
NetIncomeLoss
-24915 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2607 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
4307 USD
CY2019Q2 us-gaap Professional Fees
ProfessionalFees
4307 USD
us-gaap Professional Fees
ProfessionalFees
19960 USD
us-gaap Professional Fees
ProfessionalFees
20908 USD
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
931 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
232 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1444 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
670 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
5238 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
4539 USD
us-gaap Operating Expenses
OperatingExpenses
21404 USD
us-gaap Operating Expenses
OperatingExpenses
21578 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5238 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4539 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-21404 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-21578 USD
CY2020Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
-1217 USD
CY2019Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
-911 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
-3511 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
-2495 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1217 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-911 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3511 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2495 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6455 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5450 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24915 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24073 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6455 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5450 USD
us-gaap Net Income Loss
NetIncomeLoss
-24915 USD
us-gaap Net Income Loss
NetIncomeLoss
-24073 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2019Q4 us-gaap Profit Loss
ProfitLoss
-12628 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-102599 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-5832 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-108431 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-6455 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-114886 USD
CY2018Q4 us-gaap Profit Loss
ProfitLoss
-12055 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-71709 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-6568 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-78277 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-5450 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-83727 USD
us-gaap Net Income Loss
NetIncomeLoss
-24073 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7999 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29578 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2494 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
27000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2578 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1602 USD
us-gaap Interest Paid Net
InterestPaidNet
-0 USD
us-gaap Interest Paid Net
InterestPaidNet
-0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
-0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
-0 USD
us-gaap Use Of Estimates
UseOfEstimates
A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at April 30, 2020. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to develop its business plan.
CY2019Q4 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
150000 USD

Files In Submission

Name View Source Status
0001640334-20-001512-index-headers.html Edgar Link pending
0001640334-20-001512-index.html Edgar Link pending
0001640334-20-001512.txt Edgar Link pending
0001640334-20-001512-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pnht-20200430.xsd Edgar Link pending
pnht-20200430_cal.xml Edgar Link unprocessable
pnht-20200430_def.xml Edgar Link unprocessable
pnht-20200430_lab.xml Edgar Link unprocessable
pnht-20200430_pre.xml Edgar Link unprocessable
pnht_10q.htm Edgar Link pending
pnht_10q_htm.xml Edgar Link completed
pnht_ex311.htm Edgar Link pending
pnht_ex312.htm Edgar Link pending
pnht_ex321.htm Edgar Link pending
pnht_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending